6th Jul 2010 12:42
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 1142 GMT [Dow Jones] Investec Securities cuts Smith & Nephew (SN.LN) price target to 630p from 757p. Investec lowers the PER
Read more5th Jul 2010 09:04
0804 GMT [Dow Jones] UBS cuts Smith & Nephew (SN.LN) price target to 730p from 760p, citing currency headwinds. Says continuing economic uncertainty will likely see the management taking a cautious stance on its sales outlook in '10. Cuts its '10 EPS estimate to $69.23 from $70.52, and '11 EPS estim
Read more5th Jul 2010 09:04
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0804 GMT [Dow Jones] UBS cuts Smith & Nephew (SN.LN) price target to 730p from 760p, citing currency headwinds. Says continui
Read more2nd Jul 2010 15:24
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 1424 GMT [Dow Jones] Smith & Nephew (SN.LN) shares -5.1% at 584p, with traders citing a note by JPMorgan Thursday in which th
Read more2nd Jul 2010 15:24
1424 GMT [Dow Jones] Smith & Nephew (SN.LN) shares -5.1% at 584p, with traders citing a note by JPMorgan Thursday in which the brokerage downgrades its forecasts for the company due to currency headwinds. JPM cut its '10 EPS estimate to $0.66 from $0.70 and its '11 EPS estimate to $0.77 from $0.79 t
Read more2nd Jul 2010 14:42
Stocks on the fall in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 1342 GMT [Dow Jones] Smith & Nephew (SN.LN) -5.3% at 583p, on market speculation that it is guiding analysts lower ahead o
Read more2nd Jul 2010 14:42
1342 GMT [Dow Jones] Smith & Nephew (SN.LN) -5.3% at 583p, on market speculation that it is guiding analysts lower ahead of the 2Q results due in August. One trader notes that the volumes are strong, exceeding the 2.9M average. Thinks though the selling looks overdone as the company's earnings impro
Read more30th Jun 2010 07:43
0643 GMT [Dow Jones] Jefferies initiates coverage of Smith & Nephew (SN.LN) at buy with 790p price target. Sees significant re-rating in the orthopedics industry and says the company is best placed for this. Says its valuation is among the most attractive in the sector and a modest acceleration in g
Read more30th Jun 2010 07:43
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0643 GMT [Dow Jones] Jefferies initiates coverage of Smith & Nephew (SN.LN) at buy with 790p price target. Sees significant r
Read more23rd Jun 2010 20:04
ANDOVER, Mass., June 23 /PRNewswire-FirstCall/ -- A US District Court judge in Texas yesterday ruled that it granted an injunction in favor of Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division. As expected the Judge also granted Arthrex's motion to stay the injunction pending an appeal of the
Read more6th May 2010 16:43
Footsie ended the day sharply lower as Greece's problems reared up again and investors fretted about the outcome of today's election. Banks were hit hard as ratings agency Moody's warned that the UK lenders are "at risk of Greek contagion". Barclays, Royal Bank of Scotland, HSBC and even Asia-foc
Read more6th May 2010 14:16
Footsie's morning gains evaporated over the lunch time session as fears over the debt crisis spreading from Greece reared up again. Banks were hit hard as ratings agency Moody's warned that the UK lenders are "at risk of Greek contagion". Barclays, Royal Bank of Scotland, HSBC and even Asia-focus
Read more6th May 2010 13:16
First quarter results from medical devices firm Smith & Nephew were ahead of expectations and Killik & Co thinks there is more to come from a company it describes as a 'world leader' in its field. "We believe the long-term outlook for the group is positive. Its markets are expected to generate mid-
Read more6th May 2010 13:14
First quarter results from medical devices firm Smith & Nephew were ahead of expectations and Killik & Co thinks there is more to come from a company it describes as a 'world leader' in its field. "We believe the long-term outlook for the group is positive. Its markets are expected to generate mid-
Read more6th May 2010 12:19
Footsie finished the morning in positive territory after a nervous start, with those looking for an excuse to buy finding plenty of reasons to do so from some of the big companies declaring results today. Fund manager Schroders is top of the tree after it said the momentum built up in 2009 has cont
Read more